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Abstract.
In order to show the effect of treatment, the change between two repeated psychometric
measurements at the individual level should be estimated. The simplest method is to calculate
the absolute difference between two measurements. However, measurements obtained in a
clinical setting are often influenced by other changes not related to the treatment. One of the
typical sources of error is regression to the mean (RTM). Iachina and Bilenberg (2012) propose
a new method to adjust to the RTM effect. In this work, we will evaluate the performance of
absolute difference method and adjusted method in a simulation study.
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1. Introduction
In medical science, studies are frequently designed to investigate changes in a specific param-
eter before and after treatment. The measurements in a clinical setting are often influenced by
measurement errors, which leads to regression to the mean (RTM). RTM effect occurs whenever a
non-random sample is selected from a population and two variables that are imperfectly correlated
are measured. The less correlated the two variables the larger the effect of RTM and the more
extreme the value is from the population mean, the more room there is to regress to the mean.
This occurs when an extreme group is selected from one variable and then another variable is
measured (Bland and Altman, 1994). Thus, as Campbell and Kenny (Campbell and Kenny, 1999)
pointed out, RTM is the difference between perfect correlation and observed correlation. The prac-
tical problem caused by RTM is the need to distinguish a real change due to treatment effect from
this expected change due to the natural variation.
In the literature, several different methods are used to estimate a real change due to treatment.
In practice, in most medical papers a change is estimated in the most simple way, as a difference
between the measurement before and after the treatment (Twisk, 2003), i.e. ignoring the RTM
effect. The goal of this work is to evaluate the performance of the simplest estimating method
and compare it to the performance of a more advanced method using a simulation study. The
simulations will be constructed in orden to roughly approximate the real data from the Danish
CAMHS-database. The Danish CAMHS database is described in details in (Bilenberg et al., 2001)
2. Regression to the mean
This artefact was first mentioned by Galton (Galton, 1886), he called this phenomenon "regres-
sion towards mediocrity", and we now call it "regression to the mean".
Let X1 and X2 be random variables with joint distribution function F. Assume that X1 and
X2 have the same marginal distribution and let μ denote their common mean. The distribution F
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exhibits regression to the mean if for all c > μ,
μ 6 E[X2|X1 = c] < c,
and for all c < μ,
c < E[X2|X1 = c] 6 μ.
For simplicity, we assume that the measurements have a bivariate normal distribution with a
common variance σ2 and correlation ρ. Then for a given X1 = x the expected value of X2 will not
be equal to
E[X2|X1 = x] = x − (1 − ρ)(x − μ)
This equation shows the presence of RTM effect. It depends of both values of x − μ and of corre-
lation, ρ.
In a clinical study a sample of n patients is taken from a population and compares the average of
the pretreatment measurement with the average of posttreatment measurement in order to estimate
the treatment effect τ. If the sample is random sample from a population the difference between
averages will be an unbiased estimate of the treatment effect. However, most clinical studies use
the samples which consist of people who were hospitalised or who needs treatment. Clealy, this
subset of population is not a random sample. In this case the difference between averages does not
estimate the true treatment effect, but instead
E[ ˉX2 − ˉX1|X1 > c] = τ − (1 − ρ)
σφ( c−μ
σ
)
1 − Φ( c−μ
σ
) ,
where φ and Φ are density and cumulative density function for normal distribution. Then more ex-
treme observations defined at the first time point will, in the next point of time be closer to the mean
even if no real changes occurred (Galton, 1886; Yudkin and Stratton, 1996; Bland and Altman,
1994; Campbell and Kenny, 1999). This RTM confounds the interpretation of score change (Alli-
son et al., 2009).
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3. Estimating models
Suppose there are N hospitalised persons, M of those have one measurement of interest before
treatment and one measurement after the treatment. Other N − M persons have at least two pre-
treatment measurements. Let Yit denote response variabel or measurement of interest for subject
i at time t. Using pre-and post-treatament measurements of the response variable the treatment
effect can be estimated in different approaches. In the following we will describe two of those.
absolute difference
The simplest approach to estimate the treatment effect, and also mostly used in the clinical
trials, is to calculate the absolute difference between two measurements overtime,
τ = E[Yi1 − Yi2],
for all i = 1, ...,M i.e. ignoring the RTM effect.
adjusted difference
Using the patients who have two pre-treatment observations estimate the RTM effect fitting the
following linear regression:
Yi2 = const + aYi1 + i,
where  < N(0, 1)
Then we can adjust for this effect constructing a new corrected follow-up score:
Yi2 =
1
a
(Yi2 − const),
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where a and const are estimatetes from the previouse equation.
4. The real data
In order to show the effect of treatment in the naturalistic setting of child and adolescent mental
health services the change of Health of the Nation Outcome Scales for Children and Adolescents
(HoNOSCA) score at the individual level should be estimated. HoNOSCA is a brief scale for mea-
suring emotional and behavioural problems in children and adolescents, 4-18 years of age, and is
to be completed by multidisciplinary staff. HoNOSCA comprises 13 subscales or items measuring
disruptive/aggressive behaviours, overactivity/concentration problems, self injury, substance mis-
use, scholastic skills, physical illness, hallucinations/delusions, non organic somatic symptoms,
emotional symptoms, peer relationships, self care, family relationships, and school attendance.
All items are scored on a 0-4 point, scale ranging from "no problems" (0) to "severe problems"
(4). Thus the total score ranges from 0 to 52. HoNOSCA is an established measure of outcome
in child and adolescent mental health services (CAMHS) (Gowers et al., 1999). The score has
been evaluated in several clinical studies (Bilenberg, 2003) and (Lesinskiene et al., 2007). This
database was established in 2003 in order to improve and evaluate treatment outcome. For every
single patient referred, a number of variables are registered at referral, at the first meeting with
the patient and family, and at the end of treatment. Changes between post and pre treatment mea-
surements of HoNOSCA scores will reflect the treatment effect (Burgess et al., 2009). At present
the Danish CAMHS-database consists of a total of 4,961 persons who had a verified Hyperkinetic
Disorder (HKD) diagnosis. The following study will be based only on persons who participated
in two interviews and who have a complete assessment at both interviews, which leaves a total of
4,249 persons. The distribution of the initial HoNOSCA score is illustrated in Figure 1.
Approximately 10% of the study population does not getting any treatment, due to children/parents
not being interested in pharmacologic intervention and therefore ending services, families seeking
treatment elsewhere, or children from families moving to another district etc. There are no signifi-
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cant differences in the prognostic variables between this group of children and all other children in
the study sample at the time of the first assessment. So we assume that population of children who
does not receive any treatment is a random subpopulation of all children with HKD.
5. Design of simulation study
We are interested in evaluating the behaviour of estimates from two different approaches. For
this purpose we performed a simulation study based on a Danish CAMHS-database. We would
like to simulate three different data scenarios. Firstly, we assume that all children with HoNOSCA
score above 13.6 are diagnosed with hyperkinetic disorder. Secondly, we assume that all children
with HoNOSCA score above 13.6 is sick with the diagnosis, and additionally 80% of children with
HoNOSCA scores between 13.6 and 9, 50% of children with HoNOSCA scores between 9 and 6,
and 10% of children with HoNOSCA scores below 6 are diagnosed with hyperkinetic disorder as
well. These scenarios may be a little more realistic than the first one because clinicians usually use
other criteria than the HoNOSCA score when they diagnose children with hyperkinetic disorder.
We simulated the third scenario so that the simulated score distribution similar as possible to the
observed. The histograms of the simulated score distributions can be seen in figure 2.
In the following simulation study, we focus on settings where treatment effect b = 0, 1, 2, 3
and number of individuals n = 5000. Simulations were done using 1000 replications. In every
replication sampling of response variable at the time 1 was generated in the following way
Yi1 = Xi + ri
where Xi ∼ N(10.5, 8.5) and ri denote a personal variability, ri ∼ N(0, s), her s ∈ (0, 5).
The conditional sampling was generated from the following scenarios,
7
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Scenario I
p = 1 if Yi1 > 13.6
p = 0 if Yi1 < 13.6
Scenario II
p = 1 if Yi1 > 13.6
p = 0.8 if Yi1 < 13.6 and Xi1 > 9
p = 0.5 if Yi1 < 9 and Xi1 > 6
p = 0.1 if Yi1 < 6 and Xi1 > 0
p = 0 if Yi1 < 0
Scenario III
p = 1 if Yi1 > 13.6
p = 0.99 if Yi1 < 13.6 and Xi1 > 11
p = 0.9 if Yi1 < 11 and Xi1 > 10
p = 0.8 if Yi1 < 10 and Xi1 > 9
p = 0.5 if Yi1 < 9 and Xi1 > 6
p = 0.1 if Yi1 < 6 and Xi1 > 3
p = 0.01 if Yi1 < 3 and Xi1 > 0
p = 0 if Yi1 < 0
The response variable at the time 2 was defined in the following way
Yi2 = Yi1 + ri if k < −1.3
Yi2 = Yi1 + ri + b if k > −1.3
8
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
where b represents the treatment effect and b ∈ (0, 1, 2, 3), k ∼ N(0, 1). On that way we have
simulated that approximately 10% individuals will be in the non treatment group.
There were simulated 1000 realizations for scenario I, II and III for b = 0, 1, 2, 3 and for
s ∈ (0, 5) in 0.5 intervals, then using absolute and adjusted approaches we estimated the treatment
effect. The estimated averages and 95% interfractile intervals for the treatment effect are graphi-
cally depicted i figures 3-5. Moreover, we simulated 1000 realizatoins of data set for scenario III
b = 3 where N = 500 and N = 50000. The results of the simulation are shown in figure 6.
6. Random number generator
We used STATA version 12 to develop our simulation and although STATA runs in an inter-
preted environment, which is somewhat slower than optimized FORTRAN or C code, it provides
routines for graphing and the running of simulations which is suitable for a simulations study.
Random number generators (RNG) are used everywhere in today’s software, e.g. in com-
puter games, stock exchange algorithms, heuristic optimization algorithms, simulation studies etc.
Clearly RNG has an important role in software development. However, history has shown several
potential pitfalls in generating random numbers and care should be taken upon the selection of a
good RNG. For this selection the sequence of randomly generated numbers should at least satisfy
the following properties: the sequence should be uniform, it should be independent and repro-
ducible, and it should have a long period so that the sequence does not start to repeat itself (Knuth,
1997; Klimasauskas, 2002; Jones, 2010).
To meet the above criteria and to ensure our results would not rely on a single RNG, we
run experiments using three different RNG: 1) In STATA the built-in RNG is "The KISS gen-
erator" (Marsaglia and Zaman, 1993; StataCorp, 2011) that has a period length that lies above 2123.
Additionally, we used 2) "Mersenne Twister" (Matsumoto and Nishimura, 1998) that has a very
long period of 219937−1, and 3) "Mother-of-all" (Marsaglia, 1994) that has a period length that lies
above 259. For both of these we made re-implementations of a C++ class library of random num-
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ber generators provided by A. Fog (Fog, 2010). This was done using GCC/C++ to create shared
objects, also known as Stata Plugins, to link with STATA. These 1-3) are all commonly known
RNG that passes numerous tests for statistical randomness, including the Diehard tests (Marsaglia,
1997).
In a single simulation we use RNG to generate random numbers from the uniform (0,1] dis-
tribution to create the population samples of interest. In the worst case we draw 4 × 108 < 229
random numbers in a sequence. That is, for each of 50.000 observations, we draw 8 different
random numbers for the creation of population samples, finally this is repeated 1000 times.
When we run experiments, the variables shown in table 1 and described in above sections are
permuted in a nested loop giving us 3×3×4×11 = 396 combinations of arguments which is set to
simulate. At the end of each simulation mean values are calculated and appended to an output file
together with the current set of arguments, following the guidelines given in (Burton et al., 2006).
To initialize the RNG we tried with different random seed values which had no influence on
our results and we have run all simulations with seed = 123.
We simulated also 1000 realizatoins of data set for scenario III b = 3 where N = 5000 using
three different Random Number Generators. The results of the simulation are shown in figure 7.
7. Results of the simulatin study
Figures 3-5 shows the estimated treatment effect and 95% interfractile intervals estimated by
absolute and adjusted methods for the different scenarios and b = 0, 1, 2, 3, s ∈ (0, 5).
First we will underline,that all figures show that both treatment estimates and the 95% inter-
fractile intervals estimated by absolute and adjusted methods are equal and unbiased for s = 1,
i.e. then there are no persons variability in the measurement of HoNOSCA score. Figures shows
that estimational results for the both absolute and adjusted method for all three scenalios are very
similar.
Scenario I: For b equal to zero, i.e. no treatment effect, the absolute method estimates the
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highest bias for s equal to 5 (-2.65 with 95% interfractile interval (-2.9;-2.4)) and the adjusted
method estimates the highest bias also for s equal to 5 (-0.02 (-1.1; 1.2)). For b equal to one,
the absolute method estimates the highest bias for s equal to 5 (-2.6 (-2.9;-2.3)) and the adjusted
method estimates the highest bias also for s equal to 5 (0.3 (-0.2; 1.7)). For b equal to two and
three again both methods estimate the highest bias for s equal to 5. The absolute method estimates
bias equal to -2.6 (-2.9; -2.3) for b =2 and corresponding -2.6 (-2.9; -2.4) for b =3. The adjusted
method estimates bias equal to 0.7 (-0.5; 2.1) for b =2 and corresponding 1.7 (-0.2; 2.6) for b =3.
Scenario II: For b equal to zero, i.e. no treatment effect, the absolute method estimates the
highest bias for s equal to 5 (-1.6 with 95% interfractile interval (-1.8;-1.4)) and the adjusted
method estimates the highest bias also for s equal to 5 (-0.9 (-1.4; 0.9)). For b equal to one,
the absolute method estimates the highest bias for s equal to 5 (-1.6 (-1.8;-1.4)) and the adjusted
method estimates the highest bias also for s equal to 5 (0.3 (0.4; 1.3)). For b equal to two and
three again both methods estimate the highest bias for s equal to 5. The absolute method estimates
bias equal to -1.6 (-1.8; -1.4) for b =2 and corresponding -1.6 (-1.8; -1.4) for b =3. The adjusted
method estimates bias equal to 0.7 (-0.5; 2.2) for b =2 and corresponding 1.1 (0.1; 2.2) for b =3.
Scenario III: Estimating results for the scenario III are almost identical to estimating results
from the scenario II. For b equal to zero, i.e. no treatment effect, the absolute method estimates
the highest bias for s equal to 5 (-2.65 with 95% interfractile interval (-2.8;-2.4)) and the adjusted
method estimates the highest bias also for s equal to 5 (-0.01 (-0.9; 0.9)). For b equal to one,
the absolute method estimates the highest bias for s equal to 5 (-2.6 (-2.8;-2.4)) and the adjusted
method estimates the highest bias also for s equal to 5 (0.3 (-0.6; 1.3)). For b equal to two and
three again both methods estimate the highest bias for s equal to 5. The absolute method estimates
bias equal to -2.6 (-2.8; -2.4) for b =2 and corresponding -2.6 (-2.8; -2.4) for b =3. The adjusted
method estimates bias equal to 0.7 (-0.3; 1.7) for b =2 and corresponding 1.1 (0.1; 2.1) for b =3.
For all three scenarios and for all b absolute approach estimates are biased and bias grows for
s > 0.
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Figure 6 shows the results of a simulation study for n = 500, n = 5000 and n = 50000, figure
7 shows the results of a simulation study for n = 5000 using three different Random Number
Generators. According to these figures, the Random Number Generator and the sample size does
not seems to have any influence on the treatment estimate and 95% interfractile intervals became
less for bigger sample size, as expected.
8. Conclusion
From the results of the simulation study we can see that bias estimated for scenario I is bigger
than for scenarion II and III. The treatment effect estimated by adjusted method is unbiased for
b = 0, and slightly biased for b = 1, 2, 3 bias grows for s bigger than 1. Moreover, the 95%
interfractile intervals estimated by adjusted method became bigger for bigger s.
We can conclude that the treatment effect estimated by the absolute difference approach will be
biased when personal variability is different from zero. The parameters estimated by the adjusted
approach are unbiased only when there is no treatment effect and bias grows when the treatment
effect grows. Unfortunately, the variability of these estimates is very big for a big personal vari-
ability.
Overall, if the measurement has a large personal variability any estimate of the difference will
have a big variability and can not be credible.
Using this simulation study we will not recommend to use absolute difference approach to
estimate the difference between two measurements in any cases. We can recommend, to use the
adjusted approach instead of absolute to estimate the difference when the personal variability of
measurement is small.
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Table 1: Description of variables and constants used running simulations
in STATA 12.
Variables Description Values
seed random seed 123
reps no of repititions 1000
n no of observations 500, 5.000, 50.000
s personal variability 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5
b treatment effect 0, 1, 2, 3
sc scenario 1, 2, 3
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Figure 1: The distribution of HoNOSCA score measured children with
HKD disorder
Figure 2: The simulated distributions of HoNOSCA score after scenarios
Figure 3: Simulation results for scenario I, n=5000
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Figure 4: Simulation results for scenario II, n=5000
Figure 5: Simulation results for scenario III, n=5000
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Figure 6: Simulation results for scenario III, b=3
Figure 7: Simulation results for scenario III, b=3, n=5000 using three different Random Number
Generators
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